BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37321153)

  • 1. The right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteria.
    Haight PJ; Riedinger CJ; Backes FJ; O'Malley DM; Cosgrove CM
    Gynecol Oncol; 2023 Aug; 175():32-40. PubMed ID: 37321153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer.
    Ayhan A; Taskiran C; Celik C; Yuce K; Kucukali T
    Int J Gynecol Cancer; 2002; 12(5):448-53. PubMed ID: 12366661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
    Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
    Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of different metastatic sites for patients with FIGO stage IVB endometrial cancer after surgery: A SEER database analysis.
    Li H; Zhang R; Chen C; Wu C; Lin H; Li J; Lin Z
    J Surg Oncol; 2020 Oct; 122(5):941-948. PubMed ID: 32682330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal cytoreduction followed by chemoradiation in stage IVB uterine serous carcinoma.
    McEachron J; Zhou N; Hastings V; Bennett M; Gorelick C; Kanis MJ; Lee YC
    Cancer Treat Res Commun; 2022; 33():100631. PubMed ID: 36096033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).
    Chen JR; Chang TC; Fu HC; Lau HY; Chen IH; Ke YM; Liang YL; Chiang AJ; Huang CY; Chen YC; Hong MK; Wang YC; Huang KF; Hsiao SM; Wang PH
    Medicine (Baltimore); 2016 Apr; 95(15):e3330. PubMed ID: 27082583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIGO 2023 endometrial staging: a leap of faith into the new "prognostic based' rather than "anatomical based" staging-too fast too furious??
    Bassetty KC; Begum D; Barmon D; Baruah U; Gupta S; Kumar M; Nath J; Khanikar D; Bhattacharyya M; Roy PS
    J Cancer Res Clin Oncol; 2024 May; 150(5):251. PubMed ID: 38733417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of 2009 FIGO staging system on the diagnostic value of preoperative MRI staging of endometrial carcinoma].
    Yu XD; Ouyang H; Lin M; Zhou CW; Zhang R
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):692-6. PubMed ID: 22340052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival.
    Bristow RE; Zerbe MJ; Rosenshein NB; Grumbine FC; Montz FJ
    Gynecol Oncol; 2000 Aug; 78(2):85-91. PubMed ID: 10926785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic patterns do not provide additional prognostic information for patients with FIGO stage IV high-grade serous ovarian cancer.
    Feng Z; Wen H; Ju X; Bi R; Chen X; Yang W; Wu X
    J Surg Oncol; 2020 Aug; 122(2):315-319. PubMed ID: 32500598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage IVB endometrial cancer confined to the abdomen: is chemotherapy superior to radiotherapy?
    Cirik DA; Karalok A; Ureyen I; Tasci T; Koc S; Turan T; Tulunay G
    Eur J Gynaecol Oncol; 2016; 37(2):226-31. PubMed ID: 27172750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
    Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
    Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification.
    Werner HM; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; Amant F; Salvesen HB;
    Gynecol Oncol; 2012 Apr; 125(1):103-8. PubMed ID: 22100838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of the subclassification of Müllerian cancer stage IV in the FIGO 2014 staging system with a focus of extra-abdominal lymph node metastases.
    Yasunaga M; Yahata H; Okugawa K; Hori E; Kodama K; Yagi H; Ohgami T; Onoyama I; Asanoma K; Kato K
    Int J Clin Oncol; 2021 Jul; 26(7):1330-1335. PubMed ID: 33786711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Using Immunohistochemical Markers and Clinicopathological Factors to Predict the Prognostic Survival of Different Types of Endometrial Cancer Recurrence].
    Huang Z; Jiang P; Jia MZ; Li L; Deng Y; Lai L; Hu ZY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):489-496. PubMed ID: 34018370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen.
    Lee LJ; Demaria R; Berkowitz R; Matulonis U; Viswanathan AN
    Gynecol Oncol; 2014 Jan; 132(1):65-9. PubMed ID: 24211401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.